Press release
Cervical Cancer Diagnostic Tests Market: Focus on the Future, Things Only Getting Better
Cervical cancer is a medical condition in which cells present in the lining of the cervix - gradually develop into pre-cancerous mass of cells that ultimately turn into cancerous tumors. Two major types of cervical cancers that are typically screened and diagnosed in women include adenocarcinoma and squamous cell carcinoma. At the same time, it has been observed that approximately 90% cases of cervical cancers are squamous cell carcinoma. Virtually, almost all the cases of cervical cancer cases are due to specific types of human papillomavirus and there are more than 100 different types of HPV virus present, of which nearly 40 are sexually transmitted. Among these, about 15 different types HPV viruses are considered as high-risk type or cancer causing. Today, cervical cancer is recognized to be one of the most common types of cancers affecting U.S. women and ranks 14th in frequency. Worldwide, cervical cancer is the third most common cancer among women and the second most frequent cause of cancer-related death, accounting for almost 300,000 deaths annually.Obtain the Sample Contaning Upcoming Market Trends for Cervical Cancer Diagnostic Tests at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=736
This research report provides a detailed analysis of the global cervical cancer diagnostic tests market and helps in understanding the various driving factors for the growth of the market. The market overview section analyzes market dynamics and trends such as drivers, restraints and opportunities that influence the current nature and future status of the market. The executive summary provides detailed insights about the report and the market in general. It also contains a market snapshot, which provides a glimpse into the present scenario of the global cervical cancer diagnostic tests market. Impact factors such as market attractiveness analysis and Porter’s five forces analysis have also been explained in the market overview section of the report in order to deliver a thorough analysis of the overall competitive scenario of the global cervical cancer diagnostic tests market.
The global cervical cancer diagnostic tests market is segmented based on types of tests performed for the diagnosis of cancer patients. Based on the test types, the market is segmented into Pap smear tests, HPV testing, colposcopy, endocervical curettage procedure and others, which comprise cone biopsy and Loop Electrosurgical Excision Procedure (LEEP). Market size estimates and forecasts for the period 2012 to 2020 have been provided for each of the segments mentioned above in terms of USD million, considering 2013 as the base year for calculating market forecast and 2012 as the historical year. The CAGR (%) of each market segment for the forecast period 2014 to 2020 has also been provided along with market size estimations.
Read the Present Market Status of Cervical Cancer Diagnostic Tests at: http://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html
Geographically, the global cervical cancer diagnostic tests market has been segmented into four major regional markets: North America, Europe, Asia Pacific and Rest of World (RoW). The market size estimations and forecasts for the period 2012 to 2020 have been provided for each of these regions at a segment level, in terms of USD million along with the CAGR for the forecast period 2014 to 2020. This study further offers market recommendations for the global cervical cancer diagnostic tests market. These include factors that may play a critical role in enhancing or boosting the market in the near future, as well as steps that need to be considered to ensure success for manufacturers.
Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cervical Cancer Diagnostic Tests Market: Focus on the Future, Things Only Getting Better here
News-ID: 428206 • Views: …
More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…

North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…

Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…

Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for Cervical
Increasing Cervical And Back Pain Prevalence Drives Demand For Cervical Pillows: …
"What market dynamics are playing a key role in accelerating the growth of the cervical pillows market?
The surge in incidence of cervical and back pain is predicted to boost the growth of the cervical pillows market. Such pains often afflict the neck and upper spine, resulting in discomfort and disturbed sleep. The increasing occurrence of these problems is linked to elements like a stationary lifestyle, amplified use of electronic gadgets,…
Cervical Cancer Screening Cervical Cancer Screening Market 2024 Global Share, Ke …
Global Cervical Cancer Screening Market 2024 Research report is segmented into several key regions, with production, consumption, revenue (million USD), market share and growth rate of Cervical Cancer Screening Industry in these regions, from 2024 to 2030 (forecast), covering North America, Europe, Asia Pacific, Middle East & Africa, South & Central America.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPBT00002661/?utm_source=OpenPR&utm_medium=10759
Key Players Analysis:
Abbott
Hologic Corporation
Qiagen N.V.
F Hoffmann-La Roche
Quest Diagnostics
BD
OncoHealth Corp.
Femasys, Inc.
TruScreen
Onko Solutions
The report covers key…
Cervical Cancer Vaccines Market – Insights
Combining the analysis capabilities and data integration with the relevant findings, the report has predicted the strong future growth of the Cervical Cancer Vaccines Market in all its geographical and product segments. The Cervical Cancer Vaccines market research gathers data about the customers, marketing strategy, competitors. The Cervical Cancer Vaccines The manufacturing industry is becoming increasingly dynamic and innovative, with more number of private players enrolling the industry.
Free Download PDF…
India Cervical Cancer Screening Market India Cervical Cancer Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Overview of the Cervical Cancer
1.1 Introduction
1.2 Stages of the Cervical Cancer
1.2.1 Stage 0
1.2.2 Stage 1
1.2.3 Stage 2
1.2.4 Stage 3
1.2.5 Stage 4
Occurrence Rate of the Cervical Cancer
2.1 Incidence of the Cervical Cancer in Indian States
…
Global Cervical Cancer Diagnostic Testing Devices Market 2017, Global Cervical C …
Focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer
Global Bronchoscopic Devices Market 2017, presents a professional and in-depth study on the current state of the Bronchoscopic Devices market globally, providing basic overview of Bronchoscopic Devices market including definitions, classifications, applications and industry chain structure, Bronchoscopic Devices Market report provides development policies and plans are discussed as well as manufacturing processes and cost…
North America Cervical Dysplasia Market grows with rising awareness about cervic …
Global Cervical Dysplasia Market: Snapshot
Cervical dysplasia is one of the fastest growing market in the field of cancer diagnosis and treatment. Cervical cancer is a precancerous stage and it can be completely cured by early detection. Rising consumer awareness in this regard has led to an increased demand for cervical screenings in the past few years. Government bodies in several developed countries conduct screening programs in order to improve…